| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| GITR | HOT GIR-H5228 | Human GITR / TNFRSF18 Protein, His Tag, low endotoxin (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $345.00 100ug | ||
| GITR | HOT GIR-H5254 | Human GITR / TNFRSF18 Protein, Fc Tag, low endotoxin | Human | HEK293 | ![]() | SDS-PAGE | $340.00 100ug | ||
| GITR | Canine GITR / TNFRSF18 Protein, His Tag | Canine | HEK293 | ![]() | SDS-PAGE | $360.00 100ug | |||
| GITR | Avitag GIR-H82E5 | Biotinylated Human GITR / TNFRSF18 Protein, His,Avitag™ (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $360.00 25ug | ||
| GITR | Avitag GIR-H82F7 | Biotinylated Human GITR / TNFRSF18 Protein, Fc,Avitag™ | Human | HEK293 | ![]() | SDS-PAGE | $360.00 25ug | ||
| GITR | Mouse GITR / TNFRSF18 Protein, His Tag | Mouse | HEK293 | ![]() | SDS-PAGE | $360.00 100ug | |||
| GITR | Avitag GIR-M82E3 | Biotinylated Mouse GITR / TNFRSF18 Protein, His,Avitag™ (MALS verified) | Mouse | HEK293 | ![]() | MALSSDS-PAGE | $3675.00 25ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| BMS-986156 | BMS-986156 | Phase 2 Clinical | Bristol-Myers Squibb Company | Liver Neoplasms; Lung Neoplasms; Neoplasms; Solid tumours; Thoracic Neoplasms | Details |
| Ragifilimab | INCAGN-1876; INCAGN-01876; AGEN-1876; CM-701 | Phase 2 Clinical | Agenus Inc, Ludwig Institute For Cancer Research | Neoplasm Metastasis; Neoplasms | Details |
| Anti-GITR antibody (BMS) | Phase 1 Clinical | Bristol-Myers Squibb Company | Neoplasms | Details | |
| IBI-102 | IBI102; IBI-102 | Phase 1 Clinical | Neoplasms | Details |
